MedPath

Arana Therapeutics Ltd.

🇦🇺Australia
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website
http://www.arana.com

Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

Phase 2
Terminated
Conditions
Rheumatoid Arthritis
Interventions
Drug: Placebo
First Posted Date
2009-06-25
Last Posted Date
2010-01-06
Lead Sponsor
Arana Therapeutics Ltd
Target Recruit Count
13
Registration Number
NCT00928317
Locations
🇨🇿

Nemocnice Jihlava, Jihlava, Czech Republic

🇨🇿

ARTHROMED s. r. o., Pardubice, Czech Republic

🇨🇿

Fakultni nemocnice Plzen, Plzen - Bory, Czech Republic

and more 42 locations

Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Interventions
Drug: Placebo
First Posted Date
2009-03-03
Last Posted Date
2010-01-06
Lead Sponsor
Arana Therapeutics Ltd
Target Recruit Count
27
Registration Number
NCT00854685
Locations
🇱🇰

Departement of Rheumatology, National Hospital Sri Lanka, Colombo, Sri Lanka

© Copyright 2025. All Rights Reserved by MedPath